[Research fellowship in the curriculum of French urologists-in-training: a study by the French Association of Urologists-in-training (AFUF)]. / Place du Master 2 recherche dans la formation des jeunes urologues français : une étude de l'AFUF.

OBJECTIVES: To assess motivations, the practical organization and the funding of a research fellowship in the training curriculum of French urologists-in-training. MATERIALS AND METHODS: An online questionnaire was sent to members of the AFUF and to participants of a research training seminar "Graines et Sol" organised by the AFU, between July and September 2013. Results are presented as the median (interquartile range). RESULTS: Sixty answers out of 115 research fellows (response rate 52%) were computed. Median age was 29 years (28-30) during the research year and male proportion 75%. The AFU grant was obtained by 57.4% of applicants, 56.4% for various grants and 47.6% for the research fellowship university grant. The annual gross amount was 29,870€ (22,710-30,195), without any significant difference between residency subdivisions. Financial supplements were obtained by being on-duty (26.2%), on-call (28.6%) and replacements (25%). The research fellowship year was done between 4th and 5th years of residency (53%), for a one-year length (96.7%) and in France (86.6%). Urologic cancerology was the thematic the most studied (60%). The research fellowship was done in view of an academic career (31.7%) or was done to wait for a post-residency position (20.8%). About a quarter was being proposed a chief-residency position before the beginning of the research year. During this year, 76.7% published. About 63% were interested in pursuing with a PhD. CONCLUSION: This study confirmed the interest for a research fellowship by French urologists-in-training. Financial support thanks to grants facilitated the conduct of a research fellowship in the aim of an academic career for most of them.

[Analysis of postoperative urgenturies after prostate photovaporization by the laser Greenlight ®]. / Étude des urgenturies postopératoires après photovaporisation prostatique par laser Greenlight ®.

UNLABELLED: Urgencies are classically described after prostate photovaporization (PVP). The objective of this study was to analyze the incidence of urgency in patients who underwent PVP using the International Prostate Symptom Score (IPSS) to defined urgencies. METHOD: This is a single-center prospective cohort study assessing patients who underwent surgery between May 2005 and January 2011. The questions 2 and 4 of the IPSS and open questions were selected to evaluate urgency during the follow-up. RESULTS: Two-hundred and four patients were operated during this period and 93 complete records were analyzed. Twenty-one percent of these patients had a clinical urgency after 1 month and 1,9% at 12 months (significant improvement, P<0.001) corresponding to scores greater than 4 for questions 2 and 4 of the IPSS. Answer scores to questions 2 and 4 improved significantly over 12 months (P<0.001). The clinical urgencies decreased significantly as well as answers to questions 2 and 4 of the IPSS. CONCLUSION: Urgencies decreased significantly between 3 and 12 months of postoperative follow. Questions 2 and 4 of the IPSS score appeared to be a standardized definition of these urgencies.

[Perioperative and early postoperative results of photoselective vaporization of the prostate using fiber 4090 (providing 120 watts) versus fiber MOXY (providing 180 watts)]. / Résultats périopératoires et postopératoires précoces de la photovaporisation prostatique au laser Greenlight XPS selon l'utilisation d'une fibre 4090 délivrant 120 watts ou d'une fibre MOXY délivrant 180 watts.

INTRODUCTION: Photoselective vaporisation of the prostate (PVP) is a surgical alternative to transurethral resection of the prostate (TURP). The goal of this study was to compare the new AMS MOXY fiber which provide 180 watts power to the 4090 fiber 120 watts power source currently used in benign prostatic hyperplasia. The assessment criteria were peroperative and early postoperative data. METHOD: This study was a monocentric prospective trial comparing two parallel groups of treatment: prostatic vaporisation with MOXY fiber (180 watts) against 4090 fiber (120 watts) in patients operated by an experienced surgeon. The urinary catheter was removed the day after the intervention and the patient was allowed to quit after a clinical examination. All the patients had a routine consultation at 1 month: clinical examination, max flow rate, biological results and results of autoquestionnaires. RESULTS: This study included 50 patients. The two groups were similar at the inclusion: age, urinary catheter, and prostate volume. The operative data show a decrease of vaporization duration (29 minutes versus 36 minutes, P=0.009) with an energy delivered increased (281 kJoules versus 223 kJoules, P=0.036) and with similar postoperative data: duration of urinary catheterization (3.8 days versus 3.6 days, P=0.908), length of stay (1.6 days versus 1.8 days, P=0.371). The 1-month results were similar between the two groups. CONCLUSION: The new fiber AMS 180 watts ROXY offer similar postoperative data to the 4090 fiber with improved operative duration and energy delivered.